Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Avery Dennison Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $13.1B | |
|---|---|---|
| Revenue (ttm) | 9.2B | |
| Net income (ttm) | 704.9M | |
| EPS (ttm) | $9.13 | |
| Shares out | 75.8M | |
| P/E (trailing) | 19.8x | |
| P/E (forward) | 15.3x | |
| Dividend | $4.00 (2.22%) | |
| Volume | 603,260 | |
| Beta | 0.80 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-01 | 2022-12-31 | 2023-12-30 | 2024-12-28 | 2025-12-31 | Trend |
| Revenue | $8.41B | $9.04B | $8.36B | $8.76B | $8.86B | +1.3% |
| Gross profit | $2.31B | $2.40B | $2.28B | $2.53B | $2.55B | +2.4% |
| Operating income | $1.06B | $1.08B | $813.7M | $1.07B | $1.06B | -0.1% |
| Net income | $740.1M | $757.1M | $503.0M | $704.9M | $688.0M | -1.8% |
| EPS (diluted) | $8.83 | $9.21 | $6.20 | $8.73 | $8.79 | -0.1% |
| EBITDA | $1.31B | $1.37B | $1.11B | $1.38B | $1.39B | +1.5% |
| R&D | $136.6M | $136.1M | $135.8M | $137.8M | $136.6M | +0.0% |
| SG&A | $1.25B | $1.33B | $1.31B | $1.42B | $1.42B | +3.3% |
Recent company headlines from major financial publishers.
Avery Dennison absorbs the guided Q3 destocking headwind of ~$0.25 per share, achieving full-year 2026 adjusted EPS within guidance of $10.00 to $10.30. Restructuring actions deliver >$60M in savings and Intelligent Labels expands moderately, anchoring intrinsic fair value at $161.18.
Customer inventory destocking resolves rapidly in Q3 2026, while Solutions Group Intelligent Labels adoption in grocery and food logistics accelerates ahead of schedule. Materials Group sustains pricing power against input inflation, driving margin expansion and full-year earnings toward the top of guidance, supporting intrinsic valuation toward the upper fair value band of $204.24.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 6.6% | $175 | $181 | $187 | $193 | $201 |
| 7.1% | $164 | $168 | $173 | $178 | $184 |
| 7.6% | $154 | $157 | $161 | $165 | $170 |
| 8.1% | $146 | $148 | $152 | $155 | $159 |
| 8.6% | $138 | $141 | $143 | $146 | $149 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
